Prenetics buys Oxsed RaViD’s rapid coronavirus diagnostics technology to slash screening time to a fraction of current tests

//Prenetics buys Oxsed RaViD’s rapid coronavirus diagnostics technology to slash screening time to a fraction of current tests

Prenetics buys Oxsed RaViD’s rapid coronavirus diagnostics technology to slash screening time to a fraction of current tests

Prenetics said it had bought exclusive rights to technology that can cut the diagnostics time for Covid-19 tests to a fraction of the time of RT-PCR tests used at Hong Kong’s airport, in an acquisition that could make cross-border travel safer and speed the creation of travel bubbles.The Hong Kong-based start-up has acquired the Oxsed RaViD test technology developed by University of Oxford scientists to screen for Covid-19 infections, according to Danny Yeung, co-founder and chief executive of…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2020-10-29T22:00:24+00:00 October 29th, 2020|Business|Comments Off on Prenetics buys Oxsed RaViD’s rapid coronavirus diagnostics technology to slash screening time to a fraction of current tests